Skip to main content
Erschienen in: International Ophthalmology 2/2011

01.04.2011

Correlation between urological alpha1-AR antagonist medication and changed intraoperative iris behavior

verfasst von: Karin Horvath, Florina Vultur

Erschienen in: International Ophthalmology | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

The aim of our study was to report on the incidence, the etiology and the management of intraoperative floppy iris syndrome (IFIS) during phacoemulsification. A non-randomized, observational, prospective study was performed for 1 year, in which 439 eyes of 438 patients (320 men and 118 women) undergoing cataract surgery by the same surgeon were enrolled. The surgeon was blinded to the patients’ drug history. The use or non-use of alpha blockers (especially tamsulosin for benign prostatic hyperplasia), duration of the treatment, presence or absence of IFIS, management of IFIS and intraoperative complications were recorded. A 3.2 mm incision was performed on 316 eyes and a 2.4 mm incision on 123 eyes. IFIS occurred in 2.96% of the patients who were taking an alpha1 antagonist. In 5.47% we identified an intraoperative iris behaviour which imitated an incipient IFIS stage called IFI-like syndrome. In cases of insufficiently dilated pupils, diluted intracameral epinephrine as well as irrigation fluid was used. Vertical chop, stability of the anterior chamber by decreasing the corneal wound size, and reducing turbulence into the anterior chamber, enhanced the surgery on eyes with IFIS. There were no intraoperative or postoperative complications. The incidence of IFIS in our study was linked to alpha blocker medication. We postulate that IFIS may be caused by other medication, but this could not be demonstrated statistically. IFIS can be well controlled during surgery, intracameral epinephrine being the main stabilizing factor.
Literatur
1.
Zurück zum Zitat Chang DF, Campbell JR (2005) Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 31:664–673PubMedCrossRef Chang DF, Campbell JR (2005) Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 31:664–673PubMedCrossRef
2.
Zurück zum Zitat Chang DF, Osher RH, Wang L, Koch DD (2007) Prospective multicentre evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology 114:957–964PubMedCrossRef Chang DF, Osher RH, Wang L, Koch DD (2007) Prospective multicentre evaluation of cataract surgery in patients taking tamsulosin (Flomax). Ophthalmology 114:957–964PubMedCrossRef
3.
Zurück zum Zitat Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD, Packard RB, Packer M (2008) Clinical experience with intraoperative floppy-iris syndrome; results of the 2008 ASCRS member survey; for the ASCRS cataract clinical committee. J Cataract Refract Surg 34:1201–1209PubMedCrossRef Chang DF, Braga-Mele R, Mamalis N, Masket S, Miller KM, Nichamin LD, Packard RB, Packer M (2008) Clinical experience with intraoperative floppy-iris syndrome; results of the 2008 ASCRS member survey; for the ASCRS cataract clinical committee. J Cataract Refract Surg 34:1201–1209PubMedCrossRef
4.
Zurück zum Zitat Chadha V, Borooah S, Tey A, Styles C, Singh J (2007) Floppy iris behaviour during cataract surgery: associations and variations. Br J Ophthalmol 91(1):40–42PubMedCrossRef Chadha V, Borooah S, Tey A, Styles C, Singh J (2007) Floppy iris behaviour during cataract surgery: associations and variations. Br J Ophthalmol 91(1):40–42PubMedCrossRef
5.
Zurück zum Zitat Manvikar S, Allen D (2006) Cataract surgery management in patients taking tamsulosin stage appoach. J Cataract Refract Surg 32(10):1611–1614PubMedCrossRef Manvikar S, Allen D (2006) Cataract surgery management in patients taking tamsulosin stage appoach. J Cataract Refract Surg 32(10):1611–1614PubMedCrossRef
6.
Zurück zum Zitat Keklicki U, Isen K, Unlu K, Celik Y, Karahan M (2008) Incidence, clinical findings and management of intraoperative floppy iris syndrome associated with tamsulosin. Acta Ophthalmol 87(3):306–309 Keklicki U, Isen K, Unlu K, Celik Y, Karahan M (2008) Incidence, clinical findings and management of intraoperative floppy iris syndrome associated with tamsulosin. Acta Ophthalmol 87(3):306–309
7.
Zurück zum Zitat Takmaz T, Can I (2007) Clinical features, complications, and incidence of intraoperative floppy iris syndrome in patients taking tamsulosin. Eur J Ophthalmol 17(6):909–913PubMed Takmaz T, Can I (2007) Clinical features, complications, and incidence of intraoperative floppy iris syndrome in patients taking tamsulosin. Eur J Ophthalmol 17(6):909–913PubMed
8.
Zurück zum Zitat Neff KD, Sandoval HP, Fernandez de Castro LE, Nowacki AS, Vroman DT, Solomon KD (2009) Factors associated with intraoperative floppy iris syndrome. Ophthalmology 16(4):658–663CrossRef Neff KD, Sandoval HP, Fernandez de Castro LE, Nowacki AS, Vroman DT, Solomon KD (2009) Factors associated with intraoperative floppy iris syndrome. Ophthalmology 16(4):658–663CrossRef
9.
Zurück zum Zitat Pärssinen O, Leppänen E, Keski-Rahkonen P, Mauriala T, Dugué B, Lehtonen M (2006) Influence of tamsulosin on the iris and its implications for cataract surgery. Invest Ophthalmol Vis Sci 47(9):3766–3771PubMedCrossRef Pärssinen O, Leppänen E, Keski-Rahkonen P, Mauriala T, Dugué B, Lehtonen M (2006) Influence of tamsulosin on the iris and its implications for cataract surgery. Invest Ophthalmol Vis Sci 47(9):3766–3771PubMedCrossRef
10.
Zurück zum Zitat Lim L-A, Frost A (2006) Iris tears secondary to intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 32:1777PubMedCrossRef Lim L-A, Frost A (2006) Iris tears secondary to intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg 32:1777PubMedCrossRef
11.
Zurück zum Zitat Shapiro BL, Petrovic V, Lee SE, Flach A, Mccaffery S, O’Brien JM (2007) Choroidal detachment following the use of tamsulosin (Flomax). Am J Ophthalmol 143:351–353PubMedCrossRef Shapiro BL, Petrovic V, Lee SE, Flach A, Mccaffery S, O’Brien JM (2007) Choroidal detachment following the use of tamsulosin (Flomax). Am J Ophthalmol 143:351–353PubMedCrossRef
12.
Zurück zum Zitat Backstrom G, Behndig A (2006) Redilating with intracameral mydriatics in phacoemulsification surgery. Acta Ophthalmol Scand 84:100–104PubMedCrossRef Backstrom G, Behndig A (2006) Redilating with intracameral mydriatics in phacoemulsification surgery. Acta Ophthalmol Scand 84:100–104PubMedCrossRef
13.
Zurück zum Zitat Shugar JK (2006) Use of epinephrine for IFIS prophylaxis. J Cataract Refract Surg 32:1074–1075PubMedCrossRef Shugar JK (2006) Use of epinephrine for IFIS prophylaxis. J Cataract Refract Surg 32:1074–1075PubMedCrossRef
14.
Zurück zum Zitat Gurbaxani A, Packard R (2007) Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye 21(3):331–332PubMedCrossRef Gurbaxani A, Packard R (2007) Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin. Eye 21(3):331–332PubMedCrossRef
15.
Zurück zum Zitat Masket S, Belani S (2007) Combined preoperative topical atropine sulphate 1% and intracameral non-preserved epinephrine hydrochloride 1:4000 (corrected) for management of intraoperative floppy iris syndrome. J Cataract Refract Surg 33:580–582PubMedCrossRef Masket S, Belani S (2007) Combined preoperative topical atropine sulphate 1% and intracameral non-preserved epinephrine hydrochloride 1:4000 (corrected) for management of intraoperative floppy iris syndrome. J Cataract Refract Surg 33:580–582PubMedCrossRef
16.
Zurück zum Zitat Bendel RE, Phillips MB (2006) Preoperative use of atropine to prevent intraoperative floppy iris syndrome in patients taking tamsulosin. J Cataract Refract Surg 32(10):1603–1605PubMedCrossRef Bendel RE, Phillips MB (2006) Preoperative use of atropine to prevent intraoperative floppy iris syndrome in patients taking tamsulosin. J Cataract Refract Surg 32(10):1603–1605PubMedCrossRef
17.
Zurück zum Zitat Arshinoff SA, Jafari M (2005) New classification of ophthalmic viscosurgical devices. J Cataract Refract Surg 31(11):2167–2171PubMedCrossRef Arshinoff SA, Jafari M (2005) New classification of ophthalmic viscosurgical devices. J Cataract Refract Surg 31(11):2167–2171PubMedCrossRef
18.
Zurück zum Zitat Arshinoff SA (2006) Modified SST-USST for tamsulosin-associated intraocular floppy iris syndrome. J Cataract Refract Surg 32:559–561PubMedCrossRef Arshinoff SA (2006) Modified SST-USST for tamsulosin-associated intraocular floppy iris syndrome. J Cataract Refract Surg 32:559–561PubMedCrossRef
19.
Zurück zum Zitat Schwinn D, Afshari N (2006) Alfa 1-adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome. Surv Ophthalmol 51(5):501–512CrossRef Schwinn D, Afshari N (2006) Alfa 1-adrenergic receptor antagonists and the iris: new mechanistic insights into floppy iris syndrome. Surv Ophthalmol 51(5):501–512CrossRef
20.
Zurück zum Zitat Calotti F, Steen D (2007) Labetalol causing intraoperative floppy iris syndrome. J Cataract Refract Surg 33(1):170–171PubMedCrossRef Calotti F, Steen D (2007) Labetalol causing intraoperative floppy iris syndrome. J Cataract Refract Surg 33(1):170–171PubMedCrossRef
21.
Zurück zum Zitat Ugarte M, Leong T, Rassanm S, Kon CH (2007) Intraoperative floppy iris syndrome, α1-adrenergic antagonists and chronic intake of mianserin: is there an association? J Cataract Refract Surg 33(1):170PubMedCrossRef Ugarte M, Leong T, Rassanm S, Kon CH (2007) Intraoperative floppy iris syndrome, α1-adrenergic antagonists and chronic intake of mianserin: is there an association? J Cataract Refract Surg 33(1):170PubMedCrossRef
22.
Zurück zum Zitat El Ghatit AM (2006) Association of IFIS and vasodepressor medication. J Cataract Refract Surg 32:546–547PubMedCrossRef El Ghatit AM (2006) Association of IFIS and vasodepressor medication. J Cataract Refract Surg 32:546–547PubMedCrossRef
23.
Zurück zum Zitat Pringle E, Packard R (2005) Antipsychotic agent as an etiologic agent of IFIS. J Cataract Refract Surg 31:2240–2241PubMedCrossRef Pringle E, Packard R (2005) Antipsychotic agent as an etiologic agent of IFIS. J Cataract Refract Surg 31:2240–2241PubMedCrossRef
Metadaten
Titel
Correlation between urological alpha1-AR antagonist medication and changed intraoperative iris behavior
verfasst von
Karin Horvath
Florina Vultur
Publikationsdatum
01.04.2011
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 2/2011
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-011-9423-2

Weitere Artikel der Ausgabe 2/2011

International Ophthalmology 2/2011 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.